ACE and chronic kidney disease: Diabetic kidney disease7437 patients with Type 2 diabetes and CKD treated with an ACE-inhibitor or an ARB at the maximum doseUACR 30–300 mg/g and an eGFR 25–90 mL/min/1.73 m2UACR 300–5000 mg/g and an eGFR >60 mL/min/1.73 m2serum K+ <4.8 mmol/L